An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of (Q80785296)
Jump to navigation
Jump to search
scientific article published on 01 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of |
scientific article published on 01 August 2007 |
Statements
An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of interferon-alpha2b (English)
B Sirohi
R Powles
D Lawrence
J Treleaven
S Kulkarni
C Rudin